Boing Boing 

EU seizes Playstation 3 imports in patent row

The European Union has seized all incoming shipments of Playstation 3s. It marks the climax in an ongoing IP war between Sony and LG, which have been patent trolling each other over various trivially obvious functions of their products. Usually these are strategic battles aimed at securing lucrative cross-licensing deals, but this one has gotten way out of hand: the impounding costs mean that LG risks financial ruin if they ultimately lose the case. Update: Sony won already. This limits the fines and costs to LG to a mere $500k, at least so far. [Thanks, DrPretto!]

EFF Pioneer Awards in San Francisco, Nov 8


I'm coming to San Francisco next month to present the 19th Annual Electronic Frontier Foundation Pioneer Awards (this year's winners are Stephen Aftergood, James Boyle, Pamela Jones and Groklaw, and Hari Krishna Prasad Vemuru -- see here for full announcement). The event's taking place at the 111 Minna Gallery at 7:30 PM, and is preceded by a "VIP event" with the Pioneer Award winners, EFF founders and board members at 6:30 (separate ticket). Funds raised from tickets go to support the EFF's amazing work (as a former employee, I can attest to how far they stretch your dollars), needed now more than ever in this era of increased pressure to surveil, control and censor the Internet.

My appearance at the Pioneer Awards is part of a longer trip that includes three days in Cedar Rapids, Iowa as guest of honor at ICON 35: A Steam Powered Convention of the Future -- they're footing the bill to get me from London to the USA. I'll be doing a post on ICON later, but I wanted to mention them here -- without their support, I couldn't do the EFF event.

The 19th Annual Pioneer Awards

ACLU prevails: US Fed Judge invalidates gene patent

United States District Court Judge Robert W. Sweet has invalidated Myriad Genetics's infamous "breast cancer patent" -- a patent on genetic mutations that cause breast cancer, which Myriad has exercised in the form of a high lab-fee for analysis on samples (Myriad threatens to sue any independent lab that performs the analysis).

The suit was brought by the ACLU and the Public Patent Foundation, who argued that US Patent and Trademark Office was wrong to grant patents on genes, as these are not patentable subject matter. The judge agreed, saying that gene patents are patents on a "law of nature" and called the isolation of genes and filing patents on them "a lawyer's trick that circumvents the prohibition on the direct patenting of the DNA in our bodies but which, in practice, reaches the same result."

Which sounds to me like a precedent against all patents that rely on isolated genes. Of course, this isn't over: the pharma/biotech stalwarts interviewed in the linked NYT piece are talking appeal, and I'm sure they'll try to go all the way to the Supreme Court.

I think that the problem here is in the untested idea that imparting exclusive rights to the genome will incentivize more research than allowing anyone to build on discoveries in the genome. It's clear that some exclusive rights provide an incentive so some people to do work. But these exclusive rights also scare off people who have good ideas but are worried about being bankrupted by someone who beat them to the patent.

Combined with that is the natural abhorrence many of us feel at the thought that genes might be patented. Genes aren't a good subject for propertization. Your genes aren't even yours -- you didn't create them. Your parents didn't really create them, either. You're your genes' steward, as are we all, and so many of us have a strong intuition that when someone else claims to own something from our genome, they're being ridiculous, or evil, or both.

Myriad Genetics, the company that holds the patents with the University of Utah Research Foundation, asked the court to dismiss the case, claiming that the work of isolating the DNA from the body transforms it and makes it patentable. Such patents, it said, have been granted for decades; the Supreme Court upheld patents on living organisms in 1980. In fact, many in the patent field had predicted the courts would throw out the suit.

Judge Sweet, however, ruled that the patents were "improperly granted" because they involved a "law of nature." He said that many critics of gene patents considered the idea that isolating a gene made it patentable "a 'lawyer's trick' that circumvents the prohibition on the direct patenting of the DNA in our bodies but which, in practice, reaches the same result."

The case could have far-reaching implications. About 20 percent of human genes have been patented, and multibillion-dollar industries have been built atop the intellectual property rights that the patents grant.

ACLU Challenges Patents On Breast Cancer Genes: BRCA

Judge Invalidates Human Gene Patent

(Thanks, Gimpy!)

(Image: Dna rendering, a Creative Commons Attribution (2.0) image from ynse's photostream)

Custom laser-engraved patent drawings on copper sheets


David and Hilary say, "Prior Art offers made-to-order engravings of patent illustrations in copper, aluminum, and brass. Thanks to the new Google Patents, the USPTO's database is now more accessible than ever. We're inviting customers to search that database for images that speak to them, then we take it from there. After considering a number of user-selected customizations, we engrave the image using our home-built CNC router into metal plate. Add a lovely frame and some matting, and you've got a top-notch conversation piece!"

Prior Art Engraving (Thanks, David and Hilary!)

Nokia sues Apple over iPhone

isitaclone.jpg

The cellphone business is patented up to its eyeballs. Dumped at ground zero in the wasteland of owned ideas, newcomers typically have to pay as much as ten percent of sales to the old guard. Apple declined Nokia's invitations to give it money, and as a result is now the target of a lawsuit filed by the Finnish manufacturer.

Read the rest